06 Sep Welcome back!
As we return from a hot summer to regular work and school schedules, this may help you avoid cooling off too fast. Please SUBSCRIBE for free e-alerts from the TI to receive email notification of...
Blog
19 Jun Invitation to BC healthcare workers to participate in a brief survey on thyroid tests
RePORT Thyroid survey invitation British Columbia (BC) healthcare workers, have you ordered a thyroid test or thyroid replacement recently? Literature and experts suggest that thyroid tests are often inappropriately ordered, and that education would be helpful...
02 May Is hydrochlorothiazide associated with an increased risk of skin cancer?
The association between hydrochlorothiazide (HCTZ) and skin cancer remains controversial. A team of investigators from the Canadian Network for Observational Drug Effect Studies (CNODES) led by Dr. Laurent Azoulay and including Dr. Greg Carney of...
12 Apr Health impacts of BC policy switch to biosimilar infliximab for inflammatory bowel disease
On September 5, 2019, British Columbia announced a new policy to switch from originator to biosimilar infliximab for patients with inflammatory bowel diseases (IBD). Subsequently, Dr. Anat Fisher and colleagues in the TI’s Pharmacoepidemiology Working...